| 1.01 0.02 (2%) | 08-08 00:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.19 | 1-year : | 1.39 |
| Resists | First : | 1.01 | Second : | 1.19 |
| Pivot price | 1 | |||
| Supports | First : | 1 | Second : | 0.99 |
| MAs | MA(5) : | 1 | MA(20) : | 1 |
| MA(100) : | 0.84 |
MA(250) : | 0.97  |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 66.6 | D(3) : | 66.6 |
| RSI | RSI(14): 79.7 | |||
| 52-week | High : | 1.49 | Low : | 0.4 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IMAC ] has closed above bottom band by 50.0%. Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.02 - 1.03 | 1.03 - 1.03 |
| Low: | 0.98 - 0.98 | 0.98 - 0.99 |
| Close: | 1 - 1.01 | 1.01 - 1.02 |
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Wed, 24 Dec 2025
IMAC Holdings Issues Secured Promissory Note - MSN
Tue, 16 Dec 2025
IMAC Holdings Secures Promissory Note for Financial Stability - TipRanks
Fri, 11 Jul 2025
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Fri, 11 Jul 2025
Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others - Quiver Quantitative
Mon, 30 Jun 2025
Switching from a 27-inch iMac to a 14-inch MacBook Pro: A Fresh Start - tidbits.com
Wed, 26 Mar 2025
Local company faces delisting | Area Stocks - Nashville Post
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 26 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 22.7 (%) |
| Held by Institutions | 16.8 (%) |
| Shares Short | 82 (K) |
| Shares Short P.Month | 36 (K) |
| EPS | -0.46 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.81 |
| Profit Margin | -75.5 % |
| Operating Margin | -72.3 % |
| Return on Assets (ttm) | -23.8 % |
| Return on Equity (ttm) | -60.8 % |
| Qtrly Rev. Growth | 27.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.58 |
| EBITDA (p.s.) | -0.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -2.23 |
| PEG Ratio | 0 |
| Price to Book value | 1.23 |
| Price to Sales | 1.73 |
| Price to Cash Flow | -3.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|